City Therapeutics, Inc. (CTY)
NASDAQ: CTY · Real-Time Price · USD
21.01
+0.24 (1.16%)
Oct 26, 2026, 10:17 AM EDT - Market open
City Therapeutics Market Cap
City Therapeutics has a market cap or net worth of $1.05 billion as of October 26, 2026. It is the 9,882nd most valuable company in the world and the 2,214th biggest in the United States.
Market Cap
1.05B
Enterprise Value
932.82M
1-Year Change
n/a
Global Rank
Country Rank
#2,214 United States
Category
ChartMarket Cap Chart
Since the IPO on October 16, 2026, City Therapeutics's market cap has increased from $895.62M to $1.05B, an increase of 16.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 1.05B | 1.16% |
| Oct 23, 2026 | 1.03B | - |
| Oct 22, 2026 | 1.03B | 1.66% |
| Oct 21, 2026 | 1.02B | -1.92% |
| Oct 20, 2026 | 1.04B | -2.94% |
| Oct 19, 2026 | 1.07B | 19.22% |
| Oct 16, 2026 | 895.62M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Seaport Therapeutics | 1.10B |
| Vor Biopharma | 1.08B |
| Replimune Group | 1.08B |
| Savara | 1.07B |
| ArriVent BioPharma | 1.04B |
| MannKind | 1.03B |
| Janux Therapeutics | 1.02B |
| MoonLake Immunotherapeutics | 1.01B |